Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description richly discloses behavior beyond annotations: it cascades through multiple lookup endpoints, degrades gracefully when GLEIF/OpenFIGI are unavailable, returns figi_candidates when a name matches multiple instruments, and clearly reports unresolved identifiers. It also explains non-equity instrument resolution and ISIN-to-LEI mapping. Even with strong annotations, this adds substantial behavioral context without contradicting them.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but front-loaded with examples and organized into clear sections. It is verbose, yet nearly every sentence adds operational detail needed for correct use. Some redundancy and length could be trimmed, but the structure supports quick scanning by an agent.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite having no output schema, the description covers input constraints, entity types, resolution behavior, ambiguous-match handling, unresolved reporting, enrichment degradation, and internal cascading. An agent has enough context to select and invoke this tool correctly without needing to infer missing behavior.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is already 100%, but the description substantially enriches parameter meaning: it explains that value must be the entity name only, warns against including full noun phrases, details accepted formats like ticker, CIK, ISIN, company name, and drug brand/generic names. This goes far beyond the schema's brief property descriptions and materially improves correct invocation.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool resolves a user-spoken name to canonical/official identifiers, with concrete examples like 'ticker for...' and 'CIK for...'. It also enumerates supported entity types and distinguishes itself from other tools by positioning it as the first stop when a name needs an ID. This is a specific verb+resource with strong scoping.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives explicit guidance to 'Use FIRST whenever you have a name but need an ID' and provides examples of suitable queries. It describes what inputs are accepted per entity type. It does not enumerate sibling alternatives or state when not to use it, but the 'Use FIRST' directive provides clear usage context.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4.1/5.0
Disambiguation3/5

Most tools have distinct roles, but there is meaningful overlap among the question-answering family (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research) and among the Polymarket analysis tools (bet_research, polymarket_arbitrage, polymarket_edges, polymarket_fill_risk). The long descriptions help separate them, but the boundaries are still subtle enough that an agent could easily pick the wrong variant.

Naming Consistency4/5

The naming is mostly snake_case and generally follows a verb_noun pattern (ask_pipeworx, compare_entities, resolve_entity, scan_dependency, validate_claim). Deviations like entity_profile, recent_alerts, recent_changes, and bare verbs (forget, recall, remember, subscribe, unsubscribe) are minor and do not seriously harm predictability.

Tool Count3/5

31 tools is heavy for a single server and suggests the surface is a bundled platform (data queries, prediction markets, memory, subscriptions, AI-visibility checks) rather than one tightly scoped domain. Each tool has a rational purpose, but the sheer count plus several meta/didactic tools makes the set feel somewhat oversized.

Completeness4/5

Core workflows are well covered: entity resolution, profiles, comparisons, grounded lookup, fact-checking, deep research, memory CRUD, and subscription lifecycle. Gaps are minor. There are no update operations for subscriptions, and some optional data sources degrade softly, but agents can accomplish the intended research, monitoring, and memory tasks without dead ends.